Cited 0 times in
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.